Company: AVD
Filing Date: 2025-04-04
Form Type: 8-K
Source: 0001193125-25-073492
Chunk: 3

Company: AMERICAN VANGUARD CORP
Filing Date: 2025-04-04
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits

  Exhibit 10.1      Amendment Number Nine to the Third Amended and Restated Loan and Security Agreement dated as of March 31, 2025, by and among Registrant, AMVAC Chemical Corporation, certain other direct and ind...  
  Exhibit 99.1      Press Release dated April 4, 2025                                                                                                                                                                     
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  104               Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                                                                                          

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  AMERICAN VANGUARD CORPORATION                                                              
  By:                                /s/ Timothy J. Donnelly                                 
                                     Timothy J. Donnelly                                     
                                     Chief Information Officer, General Counsel & Secretary